Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Next Biosciences is a leading South African biotechnology company that combines medicine, science, and technology to provide personalized health services. The company operates Africa's largest private stem cell bank, Netcells, which specializes in the cryopreservation of umbilical cord blood and tissue for future medical use. In addition to stem cell banking, Next Biosciences offers a comprehensive range of genetic screening services through its Genesis division, including non-invasive prenatal testing and pre-implantation genetic testing. The company also manufactures biological products such as amniotic membrane tissues for ophthalmic and wound care applications. By investing in state-of-the-art laboratory infrastructure, Next Biosciences remains at the forefront of regenerative medicine and diagnostic innovation in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Next Biosciences.